What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Heart failure
Michael Böhm mainly investigates Internal medicine, Cardiology, Endocrinology, Heart failure and Surgery.
His study in Blood pressure, Endothelium, Myocardial infarction, Coronary artery disease and Renal sympathetic denervation falls under the purview of Internal medicine.
His research in Blood pressure intersects with topics in Ambulatory, Denervation and Intensive care medicine.
He works in the field of Cardiology, namely Ejection fraction.
His work deals with themes such as Sinus rhythm, Ivabradine, Heart rate and Quality of life, which intersect with Heart failure.
His work on Catheter and Angiography as part of general Surgery study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His most cited work include:
- Circulating endothelial progenitor cells and cardiovascular outcomes. (1795 citations)
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock (1300 citations)
- 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. (946 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Cardiology, Heart failure, Endocrinology and Blood pressure.
He integrates Internal medicine with In patient in his study.
His Cardiology research is multidisciplinary, incorporating perspectives in Ivabradine, Clinical trial and Surgery.
His Heart failure research integrates issues from Intensive care medicine, Placebo, Clinical endpoint, Hazard ratio and Heart disease.
His works in Angiotensin II, Angiotensin II receptor type 1 and Renin–angiotensin system are all subjects of inquiry into Endocrinology.
His Blood pressure research is multidisciplinary, relying on both Anesthesia and Kidney.
He most often published in these fields:
- Internal medicine (66.47%)
- Cardiology (48.61%)
- Heart failure (26.18%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (66.47%)
- Cardiology (48.61%)
- Heart failure (26.18%)
In recent papers he was focusing on the following fields of study:
Michael Böhm mainly focuses on Internal medicine, Cardiology, Heart failure, Blood pressure and Denervation.
Internal medicine and In patient are two areas of study in which Michael Böhm engages in interdisciplinary research.
His work in Cardiology covers topics such as Stroke which are related to areas like Cardiovascular outcomes.
His biological study spans a wide range of topics, including Placebo, Ivabradine, Interquartile range and Intensive care medicine.
Michael Böhm has included themes like Ambulatory and Kidney in his Blood pressure study.
His Denervation research incorporates elements of Renal artery, Ambulatory blood pressure and Sympathectomy, Surgery, Catheter.
Between 2015 and 2021, his most popular works were:
- Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases (358 citations)
- Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (212 citations)
- Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. (174 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cardiology
- Heart failure
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Ejection fraction and Atrial fibrillation.
Michael Böhm connects Internal medicine with In patient in his study.
His work carried out in the field of Cardiology brings together such families of science as Stroke, Anesthesia and Blood pressure, Heart rate.
His research integrates issues of Placebo, Ivabradine, Randomized controlled trial and Intensive care medicine in his study of Heart failure.
The various areas that he examines in his Ejection fraction study include Tolerability, Interquartile range and Heart transplantation.
His Atrial fibrillation study incorporates themes from Cathepsin, Endocrinology and Bradykinin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
